UT Health San Antonio to lead $11 million, NIH-funded study of a first-ever oral chlamydia vaccine
SAN ANTONIO, May 9, 2024 – The study of a novel oral vaccine that could protect against chlamydia infection has...
Cedric L. covers immunology and infectious diseases, including immune response, pathogens, vaccines, outbreaks, antimicrobial resistance, and One Health research.
SAN ANTONIO, May 9, 2024 – The study of a novel oral vaccine that could protect against chlamydia infection has...
Scientists from Trinity College Dublin have made an important breakthrough that offers promise for developing new immune therapies for cancer....
A major clinical trial has found that an additional COVID 19 vaccine dose led to the majority of clinically extremely...
May 8, 2024, SEOUL, Republic of Korea, HOUSTON, USA, and PANAMA CITY, Panama — The International Vaccine Institute (IVI), an...
Food-borne diseases like typhoid, caused by Salmonella Typhimurium, are a severe threat to public health, especially in India. The indiscriminate...
Vaccines save lives, as proven during the recent pandemic, but one component of most vaccines — including the Novavax COVID-19...
Researchers have developed a new vaccine technology that has been shown in mice to provide protection against a broad range...
Expanding a lymph node, boosting a vaccineCredit: Wyss Institute at Harvard University Expanding a lymph node, boosting a vaccine A...
Acute myeloid leukemia (AML) is a type of blood cancer that forms in the soft marrow of the bones, typically...
East Hanover, NJ – May 3, 2024 – Following a two-month decline, the employment of individuals with disabilities returns to...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine